Adaptimmune Therapeutics (ADAP) null Earnings

27FebConfirmed
May 18
Aug 18
Nov 18
Feb 19
-0.48
-0.3
-0.12
0.06

Details

Expected EPS
-0.32
Actual EPS
-0.36
Surprise EPS
-0.04
Surprise Percent
+12.5%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.36 per share for .

0 Comments

Share your thoughts